Oligomeropathies, inflammation and prion protein binding
The central role of oligomers, small soluble aggregates of misfolded proteins, in the pathogenesis of neurodegenerative disorders is recognized in numerous experimental conditions and is compatible with clinical evidence. To underline this concept, some years ago we coined the term oligomeropathies...
Main Authors: | Gianluigi Forloni, Pietro La Vitola, Claudia Balducci |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.822420/full |
Similar Items
-
Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults
by: Heewon Bae, et al.
Published: (2023-12-01) -
Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity
by: Danira Toral-Rios, et al.
Published: (2020-10-01) -
Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
by: Wataru Araki, et al.
Published: (2022-01-01) -
Alpha Synuclein: Neurodegeneration and Inflammation
by: Gianluigi Forloni
Published: (2023-03-01) -
AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy
by: Fodil Azzaz, et al.
Published: (2023-01-01)